"When I started working in autism, I never imagined that we'd have the amount of progress that we have now. It gives me hope that we can even do more."
Daniel Geschwind, M.D., Ph.D., was one of two winners of the Ruane Prize for Outstanding Achievement in Child and Adolescent Research in 2012. Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Chair in Human Genetics and is a professor of neurology and psychiatry at the University of California, Los Angeles (UCLA) School of Medicine. He is director of the Neurogenetics Program and the Center for Autism Research and Treatment (CART) and co-director of the Center for Neurobehavioral Genetics at UCLA. In addition to his fundamental quest to understand the genetic basis of human higher cognition, Dr. Geschwind is working to develop effective, targeted therapeutics for brain and behavior disorders such as autism. He and his team integrate basic neuroscience investigations with advanced technologies, such as computational and bioinformatics methods and systems biology to analyze gene expression data in the brain. Dr. Geschwind also provided the leadership that led to the Autism Genetic Resource Exchange, a national resource for the study of Autism Spectrum Disorders.
“We're in this time of extraordinary promise, where we have the most extraordinary tools we've ever had... I really think we're on the precipice in a very positive way of really a totally new neuropsychiatry.”
Dr. Geschwind was recognized for his career of work at the Brain & Behavior Research Foundation National Awards Dinner in New York City in October, 2012 with the Ruane Prize for Outstanding Achievement in Child and Adolescent Researchh.